Reuters -- Dutch biotech Crucell said it will boost R&D funding by more than a third, after an investment by U.S. giant Johnson & Johnson (JNJ.N), as it aims to find a new growth engine.
Reuters -- Dutch biotech Crucell said it will boost R&D funding by more than a third, after an investment by U.S. giant Johnson & Johnson (JNJ.N), as it aims to find a new growth engine.
